DM
Deerfield Management Portfolio holdings
AUM
$5.51B
This Quarter Return
+33.56%
1 Year Return
+12.76%
3 Year Return
+152.98%
5 Year Return
+204.91%
10 Year Return
+993.1%
AUM
$5.42B
AUM Growth
+$5.42B
(+19%)
Cap. Flow
+$277M
Cap. Flow
% of AUM
5.11%
Top 10 Holdings %
Top 10 Hldgs %
57.84%
Holding
242
New
154
Increased
21
Reduced
12
Closed
14
Top Buys
| 1 |
Oscar Health
OSCR
|
$103M |
| 2 |
Baxter International
BAX
|
$52.5M |
| 3 |
Revolution Medicines
RVMD
|
$38.4M |
| 4 |
SWTX
SpringWorks Therapeutics
SWTX
|
$36.7M |
| 5 |
FUSN
Fusion Pharmaceuticals Inc. Common Shares
FUSN
|
$34.4M |
Top Sells
| 1 |
Neurocrine Biosciences
NBIX
|
$41.2M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
$38.5M |
| 3 |
Merus
MRUS
|
$23.6M |
| 4 |
Owens & Minor
OMI
|
$23.2M |
| 5 |
Roivant Sciences
ROIV
|
$18.7M |
Sector Composition
| 1 | Healthcare | 78.16% |
| 2 | Technology | 0.1% |
| 3 | Industrials | 0.09% |
| 4 | Consumer Discretionary | 0.08% |
| 5 | Consumer Staples | 0.07% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
101
Universal Insurance Holdings
UVE
$691M
| $328K | 0.01% |
+20,505
| New | +$328K |
|
102
CareTrust REIT
CTRE
$7.66B
| $326K | 0.01% |
+14,554
| New | +$326K |
|
103
Merck
MRK
$210B
| $323K | 0.01% |
+2,960
| New | +$323K |
|
104
Utz Brands
UTZ
$1.16B
| $320K | 0.01% |
+19,732
| New | +$320K |
|
|
RCM
105
DELISTED
R1 RCM Inc. Common Stock
RCM
| $315K | 0.01% |
+29,840
| New | +$315K |
|
106
Huron Consulting
HURN
$2.37B
| $315K | 0.01% |
+3,065
| New | +$315K |
|
107
Trinity Industries
TRN
$2.3B
| $314K | 0.01% |
+11,821
| New | +$314K |
|
108
Hexcel
HXL
$5.02B
| $312K | 0.01% |
+4,232
| New | +$312K |
|
109
Quaker Houghton
KWR
$2.52B
| $306K | 0.01% |
+1,434
| New | +$306K |
|
110
Acadia Pharmaceuticals
ACAD
$4.38B
| $305K | 0.01% |
+9,728
| New | +$305K |
|
111
Marvell Technology
MRVL
$54.2B
| $304K | 0.01% |
+5,048
| New | +$304K |
|
112
Interpublic Group of Companies
IPG
$9.83B
| $304K | 0.01% |
+9,324
| New | +$304K |
|
113
iHeartMedia
IHRT
$320M
| $302K | 0.01% |
+113,251
| New | +$302K |
|
114
Alnylam Pharmaceuticals
ALNY
$58.5B
| $301K | 0.01% |
+1,574
| New | +$301K |
|
115
Incyte
INCY
$16.5B
| $293K | 0.01% |
+4,665
| New | +$293K |
|
116
NewAmsterdam Pharma Company N.V. Warrant
NAMSW
$58.3M
| $290K | 0.01% |
92,787
| – | – |
|
117
Mettler-Toledo International
MTD
$26.8B
| $289K | 0.01% |
+238
| New | +$289K |
|
118
Madrigal Pharmaceuticals
MDGL
$9.76B
| $289K | 0.01% |
+1,247
| New | +$289K |
|
119
Target
TGT
$43.6B
| $288K | 0.01% |
+2,024
| New | +$288K |
|
120
Janus International
JBI
$1.44B
| $287K | 0.01% |
+21,961
| New | +$287K |
|
121
Carriage Services
CSV
$687M
| $286K | 0.01% |
+11,444
| New | +$286K |
|
122
Fulgent Genetics
FLGT
$679M
| $284K | 0.01% |
+9,829
| New | +$284K |
|
123
CONMED
CNMD
$1.68B
| $280K | 0.01% |
+2,556
| New | +$280K |
|
124
Life Time Group Holdings
LTH
$6.14B
| $276K | 0.01% |
+18,308
| New | +$276K |
|
125
Sonic Automotive
SAH
$2.81B
| $275K | 0.01% |
+4,896
| New | +$275K |
|